70
Participants
Start Date
July 1, 2023
Primary Completion Date
October 30, 2026
Study Completion Date
October 30, 2026
Placebo
Placebo capsule 30 min before bedtime
Acetazolamide
The intervention drug will be determined based on altered endotype and administered 30 min before bedtime. Patients will only take one drug of this intervention, which will be subsequently compared to placebo. Patients with increased loop gain will be given Acetazolamide 500 mg.
Trazodone
The intervention drug will be determined based on altered endotype and administered 30 min before bedtime. Patients will only take one drug of this intervention, which will be subsequently compared to placebo. Patients with decreased arousal threshold will be given Trazodone 100 mg.
Atomoxetine and eszopiclone
The intervention drug will be determined based on altered endotype and administered 30 min before bedtime. Patients will only take one drug of this intervention, which will be subsequently compared to placebo. Patients with decreased muscle responsiveness will be given Atomoxetine and Eszopiclone 80 + 3 mg.
RECRUITING
Sleep Disorders Research Program Brigham and Women's Hospital, Boston
Brigham and Women's Hospital
OTHER